Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Losartan 25mg/5ml oral liquid
0205052N0AAAGAG
|
Losartan potassium | Losartan potassium | Cardiovascular System | No data available |
|
LumiraDx INR Test testing strips
0208020W0BFAAA0
|
LumiraDx (Reagent) | INR blood testing reagents | Cardiovascular System | No data available |
|
Luvinsta XL 80mg tablets
0212000M0BCAAAD
|
Luvinsta | Fluvastatin sodium | Cardiovascular System | No data available |
|
Mandaprin 75mg dispersible tablets
0209000A0BRAAAB
|
Mandaprin | Aspirin | Cardiovascular System | No data available |
|
Mannitol 100g/500ml (20%) infusion
0202050M0AAABAB
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 100g/500ml (20%) infusion Viaflex bags
0202050M0BCACAB
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/250ml (20%) infusion bags
0202050M0AAAEAE
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/250ml (20%) infusion Viaflex bags
0202050M0BCAIAE
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/500ml (10%) infusion
0202050M0AAAAAA
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/500ml (10%) infusion Viaflex bags
0202050M0BCADAA
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Mapemid XL 1.5mg tablets
0202010P0BKAAAD
|
Mapemid | Indapamide | Cardiovascular System | No data available |
|
Marevan 500microgram tablets
0208020V0BBAFAS
|
Marevan | Warfarin sodium | Cardiovascular System | No data available |
|
MaxEPA 1g capsules
0212000V0BBABAB
|
MaxEPA | Omega-3 marine triglycerides | Cardiovascular System | No data available |
|
MaxEPA liquid
0212000V0BBAAAA
|
MaxEPA | Omega-3 marine triglycerides | Cardiovascular System | No data available |
|
MCR-50 modified-release capsules
0206010K0BHAAAF
|
MCR-50 | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Menstralite 500mg tablets
0211000P0BEAAAC
|
Menstralite | Tranexamic acid | Cardiovascular System | No data available |
|
Metalyse 10,000unit inj vials
0210020U0BBAAAA
|
Metalyse | Tenecteplase | Cardiovascular System | No data available |
|
Metalyse 5,000unit powder for solution for injection vials
0210020U0BBACAC
|
Metalyse | Tenecteplase | Cardiovascular System | No data available |
|
Metalyse 8,000unit inj vials
0210020U0BBABAB
|
Metalyse | Tenecteplase | Cardiovascular System | No data available |
|
Metaraminol 10mg/1ml solution for injection ampoules
0207020L0AAABAB
|
Metaraminol | Metaraminol | Cardiovascular System | No data available |
|
Metenix 5mg tablets
0202010V0BBAAAA
|
Metenix | Metolazone | Cardiovascular System | No data available |
|
Methoxamine 20mg/1ml solution for injection ampoules
0207020N0AAAAAA
|
Methoxamine hydrochloride | Methoxamine hydrochloride | Cardiovascular System | No data available |
|
Methyldopa 125mg/5ml oral liquid
0205020H0AAALAL
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Methyldopa 500mg/5ml oral suspension
0205020H0AAAHAH
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Methyldopa 50mg/5ml oral liquid
0205020H0AAAJAJ
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.